We are live on
!
Find out more
AA
Antipodean Advisors Portfolio holdings
AUM
$19.5M
1-Year Est. Return
6.21%
This Fund
S&P 500
This Quarter
Est. Return
+14.04%
1 Year Est. Return
-6.21%
3 Year Est. Return
-67.79%
5 Year Est. Return
+67.26%
10 Year Est. Return
+1,117.22%
AUM
$118M
AUM Growth
-$59.3M
(-33%)
Cap. Flow
-$69.1M
Cap. Flow
% of AUM
-58.32%
Top 10 Holdings %
Top 10 Hldgs %
98.58%
Holding
19
New
3
Increased
2
Reduced
4
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$14.1M |
| 2 |
Agilent Technologies
A
|
+$8.35M |
| 3 |
EXAS
Exact Sciences
EXAS
|
+$4.07M |
| 4 |
Charter Communications
CHTR
|
+$3.98M |
| 5 |
PPLI
People Inc
PPLI
|
+$3.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SLM Corp
SLM
|
+$18.7M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$17M |
| 3 |
Meta Platforms (Facebook)
META
|
+$15.1M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$14.7M |
| 5 |
Amazon
AMZN
|
+$13.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.22% |
| 2 | Communication Services | 22.19% |
| 3 | Consumer Discretionary | 17.51% |
| 4 | Financials | 14.76% |
| 5 | Technology | 8.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EXAS
1
DELISTED
Exact Sciences
EXAS
| $27.2M | 22.96% |
577,346
+101,000
| +21% | +$4.07M |
|
|
2
Charter Communications
CHTR
$17.3B
| $22.5M | 19.01% |
62,000
+10,700
| +21% | +$3.98M |
|
|
3
Alibaba
BABA
$276B
| $15M | 12.68% |
+87,000
| New | +$14.1M |
|
4
DXC Technology
DXC
$1.91B
| $9.96M | 8.41% |
134,096
-2,312
| -2% | -$164K |
|
5
Bank of America
BAC
$429B
| $9.2M | 7.76% |
363,000
-294,000
| -45% | -$7.13M |
|
|
6
Agilent Technologies
A
$39.6B
| $8.6M | 7.26% |
+134,000
| New | +$8.35M |
|
|
FG
7
DELISTED
FGL Holdings Ordinary Shares
FG
| $8.29M | 6.99% |
740,000
| – | – |
|
|
MDCO
8
DELISTED
Medicines Co
MDCO
| $6.52M | 5.5% |
176,000
-398,434
| -69% | -$14.7M |
|
|
9
Amazon
AMZN
$2.44T
| $5.72M | 4.83% |
119,000
-266,000
| -69% | -$13.1M |
|
|
PPLI
10
People Inc
PPLI
$3.12B
| $3.76M | 3.18% |
+179,053
| New | +$3.48M |
|
11
NovaGold Resources
NG
$2.54B
| $1.68M | 1.42% |
408,000
| – | – |
|
|
OPTU
12
Optimum Communications Inc
OPTU
$298M
| – | – |
-5,000
| Closed | -$162K |
|
|
13
Bio-Rad Laboratories Class A
BIO
$8.76B
| – | – |
-75,000
| Closed | -$17M |
|
14
GoPro
GPRO
$120M
| – | – |
-71,000
| Closed | -$577K |
|
15
Lamb Weston
LW
$7.42B
| – | – |
-171,000
| Closed | -$7.53M |
|
|
16
Meta Platforms (Facebook)
META
$1.49T
| – | – |
-100,000
| Closed | -$15.1M |
|
17
PTC
PTC
$15.3B
| – | – |
-122,000
| Closed | -$6.72M |
|
18
Service Corp International
SCI
$11.8B
| – | – |
-67,000
| Closed | -$2.24M |
|
|
19
SLM Corp
SLM
$4.83B
| – | – |
-1,627,802
| Closed | -$18.7M |
|
Similar funds
CVSCT
DOS
SIC
LUGPI
RCP
IVM
CCFM
VNB
Antipodean Advisors's Q3 2017 Portfolio in Review
As of Q3 2017, Antipodean Advisors held 19 positions worth $118M, down 33% from $178M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Antipodean Advisors withdrew a net $69.1M in Q3 2017, closing 8 positions and reducing 4 holdings. Its most notable exit was SLM Corp, an estimated $18.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 19% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Antipodean Advisors opened a new position in Alibaba worth $15M.
- Antipodean Advisors's largest Q3 2017 buy was Alibaba: 87,000 shares worth $15M.
- Antipodean Advisors added most to Exact Sciences in Q3 2017, an estimated $4.07M increase.
- Antipodean Advisors's biggest Q3 2017 reduction was Medicines Co, cutting an estimated $14.7M.
- Antipodean Advisors fully exited SLM Corp in Q3 2017, selling an estimated $18.7M.
- Antipodean Advisors's ten largest holdings make up 99% of its $118M portfolio in Q3 2017.
- Antipodean Advisors opened 3 new positions and closed 8 in Q3 2017.
- Antipodean Advisors's portfolio value fell 33% quarter-over-quarter to $118M.
Based on Antipodean Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.